FindTrial
Sign In

DIALOG+ is a technology-mediated intervention, which involves a structured patient assessment covering satisfaction with eight life domains and three treatment domains (DIALOG scale) and a four-step s

2 trials

Sponsors

Queen Mary University of London

Conditions

Chronic conditions such as diabetes, hypertension, chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD) Not Applicable

Unknown Phase

A research study in Colombia to test the acceptability and feasibility of an intervention called DIALOG+, adapted to improve care for people in primary care with poor physical and mental health
Active, not recruitingISRCTN14018729
Queen Mary University of LondonChronic conditions such as diabetes, hypertension, chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD) Not Applicable
Start: 2021-01-01Target: 30Updated: 2023-11-28
A research study in Uganda to test the acceptability and feasibility of an intervention called DIALOG+, designed to improve care for people in primary care with poor physical and mental health
Active, not recruitingISRCTN50335796
Queen Mary University of LondonChronic conditions such as diabetes, hypertension, chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD) Not Applicable
Start: 2021-02-15Target: 60Updated: 2023-11-28

Related Papers

Feasibility and outcomes of using DIALOG+ in primary care to improve quality of life and mental distress of patients with long-term physical conditions: an exploratory non-controlled study in Bosnia and Herzegovina, Colombia and Uganda.
2023-11-163 citations
Feasibility, experiences and outcomes of using DIALOG+ in primary care to improve quality of life and mental distress of patients with chronic conditions: an exploratory non-controlled trial in Bosnia and Herzegovina, Colombia and Uganda.
2021-09-307 citations